TRAK vs. AYTU
TRAK (Park City Group Inc) and AYTU (Aytu BioPharma, Inc.) are both stocks. TRAK operates in Software - Application (Technology), while AYTU operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past year, TRAK returned -52.99% vs 3.21% for AYTU. At a 0.19 correlation, their price movements are largely independent.
Performance
TRAK vs. AYTU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TRAK achieves a -27.62% return, which is significantly lower than AYTU's -13.46% return.
TRAK
- 1D
- -0.22%
- 1M
- -8.04%
- 6M
- -22.75%
- YTD
- -27.62%
- 1Y
- -52.99%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
AYTU
- 1D
- 2.27%
- 1M
- 4.65%
- 6M
- -14.77%
- YTD
- -13.46%
- 1Y
- 3.21%
- 3Y*
- 7.92%
- 5Y*
- -52.78%
- 10Y*
- —
TRAK vs. AYTU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
TRAK Park City Group Inc | -27.62% | -43.84% | 19.37% |
AYTU Aytu BioPharma, Inc. | -13.46% | 52.94% | -27.35% |
Correlation
The correlation between TRAK and AYTU is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Oct 8, 2024 | 0.19 |
Fundamentals
TRAK:
$161.93M
AYTU:
$18.22M
TRAK:
$104.75
AYTU:
-$2.55
TRAK:
0.03
AYTU:
0.53
TRAK:
0.00
AYTU:
0.67
TRAK:
$5.90B
AYTU:
$56.60M
TRAK:
$5.09B
AYTU:
$36.14M
TRAK:
$1.63B
AYTU:
-$27.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TRAK vs. AYTU — Risk / Return Rank
TRAK
AYTU
TRAK vs. AYTU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Park City Group Inc (TRAK) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TRAK | AYTU | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.20 | ||
| Sortino ratioReturn per unit of downside risk | -2.45 | ||
| Omega ratioGain probability vs. loss probability | 0.77 | 1.04 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.87 | -0.05 | -0.82 |
| Martin ratioReturn relative to average drawdown | -1.37 | -0.11 | -1.26 |
Loading charts...
Drawdowns
TRAK vs. AYTU - Drawdown Comparison
The maximum TRAK drawdown since its inception was -70.93%, smaller than the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for TRAK and AYTU.
Loading charts...
Drawdown Indicators
| TRAK | AYTU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.93% | -100.00% | +29.07% |
Max Drawdown (1Y)Largest decline over 1 year | -62.46% | -35.47% | -26.99% |
Max Drawdown (3Y)Largest decline over 3 years | — | -70.24% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -98.86% | — |
Current DrawdownCurrent decline from peak | -63.60% | -100.00% | +36.40% |
Average DrawdownAverage peak-to-trough decline | -33.62% | -95.30% | +61.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 40.38% | 16.48% | +23.90% |
Volatility
TRAK vs. AYTU - Volatility Comparison
The current volatility for Park City Group Inc (TRAK) is 13.11%, while Aytu BioPharma, Inc. (AYTU) has a volatility of 13.91%. This indicates that TRAK experiences smaller price fluctuations and is considered to be less risky than AYTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TRAK | AYTU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.11% | 13.91% | -0.80% |
Volatility (6M)Calculated over the trailing 6-month period | 34.47% | 32.16% | +2.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.06% | 55.20% | -11.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.93% | 85.27% | -44.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.93% | 187.34% | -146.41% |
Dividends
TRAK vs. AYTU - Dividend Comparison
TRAK's dividend yield for the trailing twelve months is around 0.90%, while AYTU has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
AYTU Aytu BioPharma, Inc. | 0.00% | 0.00% | 0.00% |
TRAK Park City Group Inc | 0.90% | 0.62% | 0.16% |
Financials
TRAK vs. AYTU - Financials Comparison
This section allows you to compare key financial metrics between Park City Group Inc and Aytu BioPharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TRAK vs. AYTU - Profitability Comparison
TRAK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Park City Group Inc reported a gross profit of 5.08B and revenue of 5.88B. Therefore, the gross margin over that period was 86.3%.
AYTU - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Aytu BioPharma, Inc. reported a gross profit of 7.60M and revenue of 12.41M. Therefore, the gross margin over that period was 61.2%.
TRAK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Park City Group Inc reported an operating income of 2.25B and revenue of 5.88B, resulting in an operating margin of 38.3%.
AYTU - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Aytu BioPharma, Inc. reported an operating income of -4.06M and revenue of 12.41M, resulting in an operating margin of -32.8%.
TRAK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Park City Group Inc reported a net income of 1.99B and revenue of 5.88B, resulting in a net margin of 33.8%.
AYTU - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Aytu BioPharma, Inc. reported a net income of -5.62M and revenue of 12.41M, resulting in a net margin of -45.3%.
Frequently Asked Questions
TRAK and AYTU have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AYTU has higher volatility (13.91%) compared to TRAK (13.11%). In terms of maximum drawdown, TRAK dropped -70.93% vs AYTU's -100.00%.
AYTU currently has the higher Sharpe Ratio (-0.03 vs -1.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TRAK and AYTU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer